Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 21;19(8):e1010896.
doi: 10.1371/journal.pgen.1010896. eCollection 2023 Aug.

Kar4, the yeast homolog of METTL14, is required for mRNA m6A methylation and meiosis

Affiliations

Kar4, the yeast homolog of METTL14, is required for mRNA m6A methylation and meiosis

Zachory M Park et al. PLoS Genet. .

Abstract

KAR4, the yeast homolog of the mammalian mRNA N6A-methyltransferase complex component METTL14, is required for two disparate developmental programs in Saccharomyces cerevisiae: mating and meiosis. To understand KAR4's role in yeast mating and meiosis, we used a genetic screen to isolate 25 function-specific mutant alleles, which map to non-overlapping surfaces on a predicted structure of the Kar4 protein (Kar4p). Most of the mating-specific alleles (Mat-) abolish Kar4p's interaction with the transcription factor Ste12p, indicating that Kar4p's mating function is through Ste12p. In yeast, the mRNA methyltransferase complex was previously defined as comprising Ime4p (Kar4p's paralog and the homolog of mammalian METTL3), Mum2p (homolog of mammalian WTAP), and Slz1p (MIS), but not Kar4p. During meiosis, Kar4p interacts with Ime4p, Mum2p, and Slz1p. Moreover, cells lacking Kar4p have highly reduced levels of mRNA methylation during meiosis indicating that Kar4p is a key member of the methyltransferase complex, as it is in humans. Analysis of kar4Δ/Δ and 7 meiosis-specific alleles (Mei-) revealed that Kar4p is required early in meiosis, before initiation of S-phase and meiotic recombination. High copy expression of the meiotic transcriptional activator IME1 rescued the defect of these Mei- alleles. Surprisingly, Kar4p was also found to be required at a second step for the completion of meiosis and sporulation. Over-expression of IME1 in kar4Δ/Δ permits pre-meiotic S-phase, but most cells remained arrested with a monopolar spindle. Analysis of the function-specific mutants revealed that roughly half became blocked after premeiotic DNA synthesis and did not sporulate (Spo-). Loss of Kar4p's Spo function was suppressed by overexpression of RIM4, a meiotic translational regulator. Overexpression of IME1 and RIM4 together allowed sporulation of kar4Δ/Δ cells. Taken together, these data suggest that Kar4p regulates meiosis at multiple steps, presumably reflecting requirements for methylation in different stages of meiotic gene expression.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Kar4p is required early in meiosis.
(A) Fluorescence microscopy of the spindle pole body (Spc42-mCherry) and microtubules (GFP-Tub1) across a time course of meiosis (12-, 24-, and 48-hours post transfer into sporulation media) in wild type (MY 16294) and kar4Δ/Δ (MY 16295). Graphs are the quantification of the number of cells in different meiotic stages (Monopolar Spindle, Meiosis I, Meiosis II, and Spores). Experiments were run in three biological replicates for each strain and at least 100 cells were counted for each replicate. Error bars represent standard deviation. (B) Flow cytometry analysis of DNA content in wild type (MY 16616) and kar4Δ/Δ (MY 16617) across the same meiotic time course of the microscopy. DNA was stained with SYTOX Green.
Fig 2
Fig 2. Kar4p has distinct functions in mating and meiosis.
(A) Schematic of the screen used to identify separation of function mutants of KAR4. (B) Limited mating assay to determine the ability of the KAR4 alleles to facilitate mating. (Left) Growth on media selective for diploids after a limited mating assay between a strain carrying the indicated KAR4 allele in MY 11297 and kar4Δ (MY 10128). (Right) Growth of strains carrying the indicated KAR4 allele mated to kar4Δ on YPD (non-selective rich media) overnight. (C) Spot assay to assess the ability of diploid strains created in (B) carrying the different KAR4 alleles to initiate meiotic recombination after 24 hours of exposure to meiosis inducing conditions. (Left) Growth of all strains on YPD. (Right) Selection for successful recombination events by selecting for His+ CanR recombinants. Spots are 10-fold serial dilutions of 1 OD of each sample. (D) Mating (blue) and meiotic (red) defective KAR4 alleles threaded onto the AlphaFold predicted structure of Kar4p.
Fig 3
Fig 3. Kar4p engages in a function specific interaction with Ste12p and Ime4p.
(A) A one-hybrid assay to determine the ability of the different Kar4p alleles fused to the Gal Binding Domain to interact with Ste12p upon exposure to alpha-factor. Growth on selective or non-selective media both with and without 3 μM alpha-factor. Growth on SC-His media selects for alleles that can maintain an interaction with Ste12p and drive expression of the HIS3 reporter gene. (B) A two-hybrid assay was used to determine the ability of the different Kar4p alleles to interact with Ime4p fused to the Gal Activating Domain after 24 hours of exposure to meiosis inducing conditions. (Left) Growth on non-selective media. (Right) Growth on both SC-HIS and SC-ADE to select for the alleles that can maintain an interaction with Ime4p and drive expression of the two reporter genes HIS3 and ADE2. Spots are 10-fold serial dilutions of 1 OD of each sample. Strains PJ69-4A and PJ69-4@ carrying the different KAR4 alleles were used for these experiments.
Fig 4
Fig 4. Kar4p is required for mRNA m6A methylation.
(A) mRNA m6A levels measured using an ELISA-like assay. The indicated mutations were made in the SK1 strain background (MY 16325, 16326, 16351, 16353, and 16356) and samples were harvested after four hours of exposure to meiosis inducing conditions. Experiments were run in three biological replicates for each strain and error bars represent standard deviation. (B) Western Blot of 3xFLAG-Rme1p in wild type (MY 16563) and kar4Δ/Δ (MY 16569) across a time course of meiosis. Kar2p is used as a loading control. (C) Western blot of 3xMYC-Ime4p after four hours in meiosis inducing media with either 100 μM cycloheximide or an equivalent amount of DMSO in both wild type (Say914) and kar4Δ/Δ (MY 16543). (Top) 3xMYC-Ime4p levels with DMSO. (Middle) 3xMYC-Ime4p levels with cycloheximide. (Bottom) Quantification of three biological replicates of the cycloheximide chase experiment. The strains used are in the SK1 background. Kar2p is used as a loading control.
Fig 5
Fig 5. Kar4p interacts with the MIS complex components Mum2p and Slz1p.
(A) Western blots of total protein and co-IPs between Mum2p-4MYC and the alleles of Kar4p-3HA. (MY 16256 and 16257) (Top) Total protein samples from the extracts that were used for the Co-IPs. Kar2p is used as a loading control. Alleles proficient for Kar4p’s meiotic function (Mei+) are in blue and alleles in red are defective (Mei-). (Bottom) Co-IPs where Mum2p-4MYC was purified and the co-purification of Kar4p-3HA was assayed. (B) Western blots of total protein and Co-IPs between Slz1p-3HA and Kar4p-9MYC. (MY 16405 and 16409) (Left) Total protein samples from the extracts that were used for the co-IPs. “*” indicates a non-specific band. (Right) Co-IPs where Slz1p-3HA was purified and the co-purification of Kar4p-13MYC was assayed. “‡” indicates the heavy chain of IgG from the anti-HA magnetic beads used for the Co-IP. (C) Western blots of total protein and Co-IPs between Kar4p-9MYC and Slz1p-3HA. (Left) Total protein samples from the extracts that were used for the Co-IPs. (Right) Co-IPs where Kar4p-9MYC was purified and the co-purification of Slz1-3HA was assayed.
Fig 6
Fig 6. IME1 overexpression partially suppresses the kar4Δ/Δ meiotic defect.
(A) Growth of kar4Δ/Δ (MY 10128 crossed to MY 11297) cells on SC-HIS+canavanine to screen for recombination after exposure to meiosis-inducing conditions carrying either KAR4, IME1, or IME2 cloned onto high-copy number 2μ plasmids. (B) Fluorescence microscopy of the spindle pole body (Spc42-mCherry) and microtubules (GFP-Tub1) across a time course of meiosis (12-, 24-, and 48-hours post movement into sporulation media) in wild type (MY 16294) and kar4Δ/Δ (MY 16295) with IME1 overexpressed from an estradiol-inducible promoter. (C) Quantification of the number of cells in different meiotic stages (Monopolar Spindle, Meiosis I, Meiosis II, and Spores) from the microscopy in B. Experiments were run in three biological replicates for each strain and at least 100 cells were counted for each replicate. 1 μM of estradiol was used to induce expression. Error bars represent standard deviation. (D) Flow cytometry analysis of DNA content in wild type (MY 16534) and kar4Δ/Δ (MY 16531) with and without IME1 overexpressed across the same meiotic time course of the microscopy. The no IME1 overexpression control is the same used in Fig 1B. DNA was stained with SYTOX Green. (E) Western blots of Ndt80p in wild type (MY 16534) and kar4Δ/Δ (MY 16531) with IME1 overexpressed. Kar2p is used as a loading control.
Fig 7
Fig 7. IME1 expression is reduced in kar4Δ/Δ.
(A) Western blot showing GFP-Ime1p levels across a time course of meiosis in wild type (MY 16550), kar4Δ/Δ (MY 16570), and kar4Δrme1Δ/ kar4Δrme1Δ (MY 16622). Kar2p is used as a loading control. (B) Quantification of western blots in (A). Error bars represent standard error (1/2 x the range) of two biological replicates. (C) qPCR measuring IME1 transcript levels in wild type, kar4Δ/Δ, and kar4Δrme1Δ/ kar4Δrme1Δ. Data were normalized to levels of PGK1 expression. Error bars represent the standard error of three replicates. (D) Flow cytometry analysis of DNA content in wild type and kar4Δ/Δ carrying either the wild type allele of RME1 (data from Fig 1B), the hypomorphic -308A allele of RME1 (MY 16557 and 16559), or a deletion of RME1 (MY 16456 and 16566). DNA was stained with SYTOX Green.
Fig 8
Fig 8. Co-overexpression of IME1 and RIM4 permits sporulation in kar4Δ/Δ.
Sporulation of wild type (MY 16616, 16532, 16534, and 16533), kar4Δ/Δ (MY 16617, 16535, 16531, and 16536), mum2Δ/Δ (MY 16619, 16526, 16525, and 16527), ime4Δ/Δ (MY 16631, 16434, 16313, 16435), slz1Δ/Δ (MY 16620, 16537, 16538, and 16539), and ime4-cat/ime4Δ (MY 16621, 16507, 16506, and 16615) with either endogenous expression of IME1 and RIM4, overexpression of RIM4, overexpression of IME1, or overexpression of both IME1 and RIM4. 1 μM of estradiol was used to induce expression. All dyads, triads, and tetrads were counted across three biological replicates for each strain. One hundred cells were counted for each strain at each time point after 48 hours post addition of estradiol. Error bars represent standard error of three biological replicates.

Update of

Similar articles

Cited by

References

    1. Kurihara LJ, Stewart BG, Gammie AE, Rose MD. Kar4p, a karyogamy-specific component of the yeast pheromone response pathway. Mol Cell Biol. 1996;16(8):3990–4002. doi: 10.1128/MCB.16.8.3990 - DOI - PMC - PubMed
    1. Kurihara LJ, Beh CT, Latterich M, Schekman R, Rose MD. Nuclear congression and membrane fusion: two distinct events in the yeast karyogamy pathway. The Journal of Cell Biology. 1994;126(4):911–23. doi: 10.1083/jcb.126.4.911 - DOI - PMC - PubMed
    1. Bardwell L. A walk-through of the yeast mating pheromone response pathway. Peptides. 2005;26(2):339–50. doi: 10.1016/j.peptides.2004.10.002 - DOI - PMC - PubMed
    1. Lahav R, Gammie A, Tavazoie S, Rose MD. Role of transcription factor Kar4 in regulating downstream events in the Saccharomyces cerevisiae pheromone response pathway. Mol Cell Biol. 2007;27(3):818–29. doi: 10.1128/MCB.00439-06 - DOI - PMC - PubMed
    1. Su TC, Tamarkina E, Sadowski I. Organizational constraints on Ste12 cis-elements for a pheromone response in Saccharomyces cerevisiae. FEBS J. 2010;277(15):3235–48. doi: 10.1111/j.1742-4658.2010.07728.x . - DOI - PubMed

Publication types

LinkOut - more resources